Changeflow GovPing Healthcare & Life Sciences Dry Needling Trial for Sacroiliac Joint Dysfunc...
Routine Notice Added Final

Dry Needling Trial for Sacroiliac Joint Dysfunction

Favicon for changeflow.com ClinicalTrials.gov Studies
Detected
Email

Summary

ClinicalTrials.gov registered a randomized controlled trial (NCT07550933) investigating the efficacy of dry needling the sacrotuberous ligament versus sham dry needling, both combined with routine physical therapy, in patients with sacroiliac joint dysfunction. The study will measure outcomes including pain intensity, functional disability, and biomechanical changes. The trial has no enrollment information specified and is categorized as an observational/interventional study with an anticipated start date of April 24, 2026.

“The aim of the study is to investigate the efficacy of dry needling for releasing the sacrotuberous ligament in patients with sacroiliac joint dysfunctions on pain intensity, functional disability, and biomechanical changes, along with routine physical therapy compared to sham dry needling and routine physical therapy.”

NIH/NLM , verbatim from source
Published by NIH/NLM on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.

What changed

A new clinical trial registration has been published on ClinicalTrials.gov for a randomized controlled study examining whether dry needling of the sacrotuberous ligament can improve outcomes for patients with sacroiliac joint dysfunction. The trial will enroll patients into two groups: Group A receiving dry needling plus routine physical therapy, and Group B receiving sham dry needling plus routine physical therapy. The primary outcome measures include pain intensity, functional disability, and biomechanical changes. This registration documents the study protocol but does not impose compliance obligations on any party.

For healthcare providers and clinical investigators, this trial represents an emerging area of research into dry needling as an intervention for ligamentous structures, which is described as novel in the trial abstract. Physical therapy practices and pain management clinics may wish to monitor trial results for potential implications on treatment protocols for sacroiliac joint dysfunction.

Archived snapshot

Apr 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Efficacy of Dry Needling for Releasing the Sacrotuberous Ligament in Patients With Sacroiliac Joint Dysfunctions

N/A NCT07550933 Kind: NA Apr 24, 2026

Abstract

Sacroiliac joint dysfunction is a common source of low back and pelvic pain, often caused by improper load transfer through the pelvis. The sacrotuberous ligament stabilises the sacroiliac joint by limiting sacral nutation and supporting posterior pelvic structures. The sacroiliac joint connects the sacrum to the ischial tuberosity and integrates with muscles like the gluteus maximus and biceps femoris. Tightness, dysfunction, or pain in the sacrotuberous ligament can exacerbate sacroiliac joint dysfunction by altering mechanics. Dry needling is increasingly used for myofascial pain and muscle dysfunction. Applying dry needling to release ligamentous structures is novel and may improve the biomechanics of the sacroiliac joint by alleviating tension in the sacrotuberous ligament. The aim of the study is to investigate the efficacy of dry needling for releasing the sacrotuberous ligament in patients with sacroiliac joint dysfunctions on pain intensity, functional disability, and biomechanical changes, along with routine physical therapy compared to sham dry needling and routine physical therapy.

Conditions: Sacroiliac Joint Dysfunction

Interventions: Group A: Dry Needling, Group B: Sham Dry Needling

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH/NLM.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH/NLM
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Healthcare providers
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trials Physical therapy treatment
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Pharmaceuticals Medical Devices

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!